A novel δ opioid receptor-mediated enhancement of GABAA receptor function induced by stress in ventral tegmental area neurons

Journal of Physiology

Volumn 589, Issue 17, 2011, Pages 4229-4242

  Margolis, Elyssa B ^a,b   Mitchell, Jennifer M ^a,b   Hjelmstad, Gregory O ^a,b,c   Fields, Howard L ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 4 AMINOBUTYRIC ACID A RECEPTOR; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; G PROTEIN COUPLED RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PICROTOXIN; PROTEIN KINASE B; OPIATE RECEPTOR;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CELL MEMBRANE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EXCITATORY POSTSYNAPTIC POTENTIAL; FOOTSHOCK; IMMUNOCYTOCHEMISTRY; INHIBITORY POSTSYNAPTIC POTENTIAL; IONTOPHORESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM; VOLTAGE CLAMP; ANIMAL; METABOLISM; NERVE CELL;

ANIMALS; NEURONS; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, GABA-A; RECEPTORS, OPIOID; VENTRAL TEGMENTAL AREA;

EID: 80052206397     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.209023     Document Type: Article

References (48)

1. 2+ channel current in rat sensory neurons by a G-protein-independent mechanism. J Neurosci 17, 8721-8728.
2. Abood ME, Law PY & Loh HH (1985). Pertussis toxin treatment modifies opiate action in the rat brain striatum. Biochem Biophys Res Commun 127, 477-483.
3. Asano T & Ogasawara N (1986). Uncoupling of γ-aminobutyric acid B receptors from GTP-binding proteins by N-ethylmaleimide: effect of N-ethylmaleimide on purified GTP-binding proteins. Mol Pharmacol 29, 244-249.
4. Bie B, Zhang Z, Cai YQ, Zhu W, Zhang Y, Dai J, Lowenstein CJ, Weinman EJ & Pan ZZ (2010). Nerve growth factor-regulated emergence of functional δ-opioid receptors. J Neurosci 30, 5617-5628.
5. Bie B, Zhu W & Pan ZZ (2009a). Ethanol-induced δ-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala. Neuroscience 160, 348-358.
6. Bie B, Zhu W & Pan ZZ (2009b). Rewarding morphine-induced synaptic function of δ-opioid receptors on central glutamate synapses. J Pharmacol Exp Ther 329, 290-296.
7. Bogdanov Y, Michels G, Armstrong-Gold C, Haydon PG, Lindstrom J, Pangalos M & Moss SJ (2006). Synaptic GABAA receptors are directly recruited from their extrasynaptic counterparts. EMBO J 25, 4381-4389.
8. Charych EI, Yu W, Miralles CP, Serwanski DR, Li X, Rubio M & De Blas AL (2004). The brefeldin A-inhibited GDP/GTP exchange factor 2, a protein involved in vesicular trafficking, interacts with the β subunits of the GABA receptors. J Neurochem 90, 173-189.
9. Chen L & Huang LY (1991). Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron 7, 319-326.
10. B receptor agonists on the mesolimbic dopamine system. Nat Neurosci 7, 153-159.
11. Dacher M & Nugent FS (2010). Morphine-induced modulation of LTD at GABAergic synapses in the ventral tegmental area. Neuropharmacology (in press).
12. Defea K (2008). β-Arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction. Br J Pharmacol 153, S298-S309.
13. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
14. Fukuda K, Kato S, Morikawa H, Shoda T & Mori K (1996). Functional coupling of the δ-, μ-, and κ-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J Neurochem 67, 1309-1316.
15. Funk D, Vohra S & Le AD (2004). Influence of stressors on the rewarding effects of alcohol in Wistar rats: studies with alcohol deprivation and place conditioning. Psychopharmacology (Berl) 176, 82-87.
16. Gendron L, Lucido AL, Mennicken F, O'Donnell D, Vincent JP, Stroh T & Beaudet A (2006). Morphine and pain-related stimuli enhance cell surface availability of somatic δ-opioid receptors in rat dorsal root ganglia. J Neurosci 26, 953-962.
17. + current in rat sensory neurons in vitro. Neurosci Lett 212, 83-86.
18. Hack SP, Bagley EE, Chieng BC & Christie MJ (2005). Induction of δ-opioid receptor function in the midbrain after chronic morphine treatment. J Neurosci 25, 3192-3198.
19. Iegorova O, Fisyunov A & Krishtal O (2010). G-protein-independent modulation of P-type calcium channels by μ-opioids in Purkinje neurons of rat. Neurosci Lett 480, 106-111.
20. Ingram SL & Williams JT (1994). Opioid inhibition of Ih via adenylyl cyclase. Neuron 13, 179-186.
21. Law PY, Wu J, Koehler JE & Loh HH (1981). Demonstration and characterization of opiate inhibition of the striatal adenylate cyclase. J Neurochem 36, 1834-1846.
22. Leidenheimer NJ, McQuilkin SJ, Hahner LD, Whiting P & Harris RA (1992). Activation of protein kinase C selectively inhibits the γ-aminobutyric acidA receptor: role of desensitization. Mol Pharmacol 41, 1116-1123.
23. Ma J, Zhang Y, Kalyuzhny AE & Pan ZZ (2006). Emergence of functional δ-opioid receptors induced by long-term treatment with morphine. Mol Pharmacol 69, 1137-1145.
24. Margolis EB, Coker AR, Driscoll JR, Lemaitre AI & Fields HL (2010). Reliability in the identification of midbrain dopamine neurons. PLoS One 5, e15222.
25. Margolis EB, Fields HL, Hjelmstad GO & Mitchell JM (2008a). δ-Opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. J Neurosci 28, 12672-12681.
26. Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO & Fields HL (2006a). Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A 103, 2938-2942.
27. Margolis EB, Lock H, Hjelmstad GO & Fields HL (2006b). The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J Physiol 577, 907-924.
28. 2 receptor inhibition. J Neurosci 28, 8908-8913.
29. Matthews DB, Morrow AL, O'Buckley T, Flanigan TJ, Berry RB, Cook MN, Mittleman G, Goldowitz D, Tokunaga S & Silvers JM (2008). Acute mild footshock alters ethanol drinking and plasma corticosterone levels in C57BL/6J male mice, but not DBA/2J or A/J male mice. Alcohol 42, 469-476.
30. Murga C, Fukuhara S & Gutkind JS (2000). A novel role for phosphatidylinositol 3-kinase β in signalling from G protein-coupled receptors to Akt. J Biol Chem 275, 12069-12073.
31. Nugent FS, Penick EC & Kauer JA (2007). Opioids block long-term potentiation of inhibitory synapses. Nature 446, 1086-1090.
32. Olianas MC, Dedoni S & Onali P (2011a). Regulation of PI3K/Akt signalling by N-desmethylclozapine through activation of δ-opioid receptor. Eur J Pharmacol 660, 341-350.
33. Olianas MC, Dedoni S & Onali P (2011b). Signalling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells. Neuropharmacology 60, 1326-1336.
34. Onali P, Dedoni S & Olianas MC (2010). Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes. J Pharmacol Exp Ther 332, 255-265.
35. Overland AC, Kitto KF, Chabot-Dore AJ, Rothwell PE, Fairbanks CA, Stone LS & Wilcox GL (2009). Protein kinase C mediates the synergistic interaction between agonists acting at α2-adrenergic and δ-opioid receptors in spinal cord. J Neurosci 29, 13264-13273.
36. Polakiewicz RD, Schieferl SM, Gingras AC, Sonenberg N & Comb MJ (1998). μ-Opioid receptor activates signalling pathways implicated in cell survival and translational control. J Biol Chem 273, 23534-23541.
37. Shahabi NA, McAllen K & Sharp BM (2006). δ Opioid receptors stimulate Akt-dependent phosphorylation of c-jun in T cells. J Pharmacol Exp Ther 316, 933-939.
38. Shi Y, Huang FS, Chen WY, Wu Y, Tang Y & Hu Q (2000). A DPDPE-induced enhancement of inward rectifier potassium current via opioid receptor in neuroblastomaxglioma NG108-15 cells. Neurosci Res 36, 209-214.
39. Thomas P, Mortensen M, Hosie AM & Smart TG (2005). Dynamic mobility of functional GABAA receptors at inhibitory synapses. Nat Neurosci 8, 889-897.
40. + channel current by a μ-type opioid receptor. Mol Pharmacol 46, 793-798.
41. Vengeliene V, Siegmund S, Singer MV, Sinclair JD, Li TK & Spanagel R (2003). A comparative study on alcohol-preferring rat lines: effects of deprivation and stress phases on voluntary alcohol intake. Alcohol Clin Exp Res 27, 1048-1054.
42. Volpicelli JR, Ulm RR & Hopson N (1990). The bidirectional effects of shock on alcohol preference in rats. Alcohol Clin Exp Res 14, 913-916.
43. Wang Q, Liu L, Pei L, Ju W, Ahmadian G, Lu J, Wang Y, Liu F & Wang YT (2003). Control of synaptic strength, a novel function of Akt. Neuron 38, 915-928.
44. Williams JT, Christie MJ & Manzoni O (2001). Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81, 299-343.
45. Woehler A & Ponimaskin EG (2009). G protein-mediated signalling: same receptor, multiple effectors. Curr Mol Pharmacol 2, 237-248.
46. A receptor function via protein kinase C in primary sensory neurones of bullfrogs. J Physiol 496, 439-449.
47. Zhang Z & Pan ZZ (2010). Synaptic mechanism for functional synergism between δ- and μ-opioid receptors. J Neurosci 30, 4735-4745.
48. Zhao C, Slevin JT & Whiteheart SW (2007). Cellular functions of NSF: not just SNAPs and SNAREs. FEBS Lett 581, 2140-2149.